Retatrutide is a next-generation triple receptor agonist peptide studied for its effects on metabolic regulation. It targets GLP-1, GIP, and glucagon receptors, three key pathways involved in energy balance, glucose metabolism, and appetite signaling. Because of its multi-pathway mechanism, Retatrutide has become an important focus in ongoing metabolic and obesity-related research.